Damian Garde

Biography for Damian Garde

Damian is an editor with Fierce's life sciences publications, writing for FierceBiotech, FierceMedicalDevices and FierceCRO. Prior to joining Fierce, he worked for Patch.com in Maryland, and The Albuquerque Journal and Weekly Alibi in Albuquerque, NM. Damian lives in Washington, DC, and considers himself the foremost Carmelo Anthony apologist in the greater metropolitan area. You can email him at dgarde@fiercemarkets.com and follow @DamianFierce on Twitter.

Articles by Damian Garde

Boston Scientific eyes FDA with new leads

Boston Scientific has launched a U.S. trial of two next-generation leads for defibrillators and pacemakers, working toward FDA approval after completing the first implant.

Thermo soars after Life Tech deal and dials up its expectations

With its $13.6 billion acquisition of Life Technologies finally wrapped up, Thermo Fisher posted huge gains in revenue and profit in its first quarter as a combined company, raising the stakes for 2014 as it plans for more growth.

Teleflex hit with FDA warning letter over respiratory devices

The FDA has handed a warning letter to Teleflex, citing manufacturing issues at an Illinois plant that produces nebulizers, humidifiers and other respiratory technologies.

EndoStim bags a CE mark for MRI-safe reflux device

The Netherlands' EndoStim convinced European regulators that MRI scans won't harm patients using its LES system, an implant designed to to stimulate the esophagus and relieve acid reflux symptoms.

Foundation Medicine ditches plans to raise $150M

The bearish market that led Lombard Medical to delay its IPO and TriVascular Technologies to price below its range has scuttled a fundraise from diagnostics luminary Foundation Medicine.

TriVascular pockets $78M in a scaled-down IPO

Medical device outfit TriVascular Technologies picked up $78 million as it made its Wall Street debut Wednesday, pricing below its expected range amid a prolonged slump for life sciences stocks.

St. Jude rides strong ICD sales to a first-quarter bump

Despite long-running headwinds, St. Jude Medical pulled off an increase in implanted defibrillator revenue in the first quarter, helping the company swing to a small rise in sales.

GE Healthcare looks to extend its M&A streak

GE Healthcare has been no stranger to dealmaking over the past year, and the company's CEO said it has no plans to let up.

Covidien snags FDA OK for a camera-equipped feeding tube

Covidien is gearing up to launch its Kangaroo feeding tube in the U.S. after picking up FDA clearance for the device, which is outfitted with a camera that provides real-time images to physicians.

Abbott wins FDA nod for diabetes blood test

Abbott Laboratories has secured the FDA's blessing to launch its latest diabetes diagnostic, a test that can help diagnose and monitor diabetics as well as flag patients at risk for developing the disease.